Lee Babiss

Biography

     "Dr. Lee Babiss is CEO of X-Rx Inc., a PPD-majority owned biotech company that focuses on developing innovative early stage drugs in the areas of oncology, fibrosis and autoimmune diseases. Prior to that, he was PPD’s Chief Scientific Officer and Executive Vice President of Discovery Innovation. Dr. Babiss joined PPD in 2010 with more than 21 years experience leading R&D in support of drug discovery. He most recently served as President and Director of Pharmaceutical Research for F. Hoffmann-La Roche Ltd., in Basel, Switzerland, where his responsibilities included leading global laboratory functions in chemistry, discovery technologies, therapeutic proteins, non-clinical safety and informatics. He supported drug discovery efforts in oncology, neurosciences, inflammation, virology and metabolism, and was a member of the company’s pharma executive and strategic portfolios committees. Prior to joining Hoffmann-La Roche, Dr. Babiss spent seven years with Glaxo Inc., now GlaxoSmithKline. As Vice President of Biological Sciences and Genetics, he had global accountability for developing and implementing the company’s corporate genetics strategy and oncology research efforts focused on the cell cycle. Dr. Babiss earned his doctorate in microbiology from Columbia University and completed his postdoctoral fellowship at Rockefeller University, where he served as Assistant and Associate Professor. He has published more than 60 peer-reviewed scientific papers, received numerous fellowship awards and grants, and serves on several scientific advisory committees and biotech boards."  

Research Interest

     novel immunotherapies